Bernd Winterhalter
Corporate Officer/Principal bei CureVac SE
Profil
Bernd Winterhalter is currently the Chief Development Officer at CureVac SE since 2019.
Prior to this, he worked as the Executive Medical Director at Bristol-Myers Squibb GmbH & Co. KGaA from 2004 to 2018 and as the Vice President-Medical, Science & Health Economics at Pharmacia GmbH from 1997 to 2003.
He also briefly served as the Chief Development Officer at CureVac NV from 2019 to 2021.
Dr. Winterhalter holds a doctorate degree from the University of Freiburg.
Aktive Positionen von Bernd Winterhalter
Unternehmen | Position | Beginn |
---|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Corporate Officer/Principal | 01.12.2019 |
Ehemalige bekannte Positionen von Bernd Winterhalter
Unternehmen | Position | Ende |
---|---|---|
CUREVAC N.V. | Corporate Officer/Principal | 01.02.2021 |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Chief Tech/Sci/R&D Officer | 01.01.2018 |
Pharmacia GmbH | Chief Tech/Sci/R&D Officer | 01.01.2003 |
Ausbildung von Bernd Winterhalter
University of Freiburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CUREVAC N.V. | Health Technology |
Private Unternehmen | 3 |
---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Pharmacia GmbH | |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Health Technology |